Berra Yazar-Klosinski, PhD

Efficacy and Safety Results from the Confirmatory Phase 3 Randomized, Placebo-Controlled Trial of MDMA-Assisted Therapy for Treatment of Chronic PTSD With at Least Moderate Severity

Posttraumatic stress disorder (PTSD) is a serious neuropsychiatric illness for which novel treatment options are urgently needed. This multi-site, randomized, double-blind, confirmatory p...

Berra Yazar-Klosinski , PhD;

10/26/2023

No Signs of MDMA-Related Histopathological Changes to CNS in Rats and Dogs in A 28-Day Repeated Oral Dose Neurotoxicity Study

3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy is being investigated as a potential treatment option for patients with posttraumatic stress disorder (PTSD). Previous animal MDM...

Berra Yazar-Klosinski , PhD;

10/26/2023